These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23551671)

  • 1. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dyslipidaemia in childhood.
    Kusters DM; Vissers MN; Wiegman A; Kastelein JJ; Hutten BA
    Expert Opin Pharmacother; 2010 Apr; 11(5):739-53. PubMed ID: 20210683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The new 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC/EAS recommendations for the management of dyslipidemias].
    Catapano AL; Averna M; Faggiano P; Novo S
    G Ital Cardiol (Rome); 2014 Jan; 15(1):19-20. PubMed ID: 24503730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dyslipidemia management in children and adolescents: recommendations of the Nutrition Branch of the Chilean Society of Pediatrics].
    Barja Y S; Cordero B ML; Baeza L C; Hodgson B MI;
    Rev Chil Pediatr; 2014 Jun; 85(3):367-77. PubMed ID: 25697255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current ways of treating dyslipidemias to prevent atherosclerosis.
    Angelico F; Baratta F; Del Ben M
    Ther Apher Dial; 2013 Apr; 17(2):125-9. PubMed ID: 23551668
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherosclerosis prevention and treatment in children and adolescents.
    Oliveira FL; Patin RV; Escrivão MA
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):513-28. PubMed ID: 20397826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and management of dyslipidemia in children and adolescents.
    Kwiterovich PO
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4200-9. PubMed ID: 18697860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and treatment of dyslipidemias in children and adolescents.
    Daniels SR
    Horm Res Paediatr; 2011; 76 Suppl 1():47-51. PubMed ID: 21778749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of lipid-lowering drug therapy in children and adolescents.
    Avis HJ; Vissers MN; Wijburg FA; Kastelein JJ; Hutten BA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):224-31. PubMed ID: 19333879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of atherosclerosis and cardiovascular diseases].
    Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D
    Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs?
    Lipshultz SE; Schaechter J; Carrillo A; Sanchez J; Qureshi MY; Messiah SE; Hershorin ER; Wilkinson JD; Miller TL
    Pediatr Endocrinol Rev; 2012 Aug; 9(4):698-705. PubMed ID: 23304806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of guidelines for dyslipidemia in children and adolescents.
    Peterson AL; McBride PE
    WMJ; 2012 Dec; 111(6):274-81; quiz 282. PubMed ID: 23362704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid management in children.
    Zappalla FR; Gidding SS
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):171-83. PubMed ID: 19217518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on screening, etiology, and treatment of dyslipidemia in children.
    Bamba V
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3093-102. PubMed ID: 24848708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening adolescents for lipid disorders: what is the best approach?
    Jenssen BP; Jacobson MS
    Adolesc Med State Art Rev; 2008 Dec; 19(3):507-20, x. PubMed ID: 19227389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
    ; Grundy SM; Arai H; Barter P; Bersot TP; Betteridge DJ; Carmena R; Cuevas A; Davidson MH; Genest J; Kesäniemi YA; Sadikot S; Santos RD; Susekov A; Sy R; Tokgozoglu L; Watts GF; Zhao D;
    Clin Investig Arterioscler; 2014; 26(1):33-7. PubMed ID: 24169377
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to deal with familial dyslipidemia in clinical practice?].
    Brun N; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):494-6, 498-500. PubMed ID: 22471110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.
    Ascaso JF; Millán J; Hernández-Mijares A; Blasco M; Brea Á; Díaz Á; Mantilla T; Pedro-Botet J; Pintó X;
    Clin Investig Arterioscler; 2017; 29(2):86-91. PubMed ID: 28185675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.